Results 171 to 180 of about 240,114 (259)

Neuroprotective effects and mechanisms of the YiQiWenYangSanHan formula on Parkinson's disease mice. [PDF]

IBRO Neurosci Rep
Liu J, Di D, Sun S, Sun Y, Zhou S, Liu J, Qin Z, Yang X, Wang X, Xu Z, Zhu B, Wu H.   +11 more
europepmc   +1 more source

Self‐Administered Taste Testing Without Water: Normative Data for the 53‐Item Waterless Empirical Taste Test (WETT)

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background According to the National Health and Nutrition Examination Survey (NHANES), more than 20 million Americans suffer from chronic taste problems. Unfortunately, quantitative testing is rarely performed, self‐reports are inaccurate, and “taste” is often confused with olfaction‐dependent flavors.
Richard L. Doty, Ryan Sharetts, Shima T. Moein   +2 more
wiley   +1 more source

ZKSCAN3 affects the autophagy‑lysosome pathway through TFEB in Parkinson's disease. [PDF]

Biomed Rep
Yang M, Lin S, Sun B, Chen W, Liu J, Chen M.   +5 more
europepmc   +1 more source

Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for primary care

Alzheimer's &Dementia, EarlyView.
Abstract US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer's disease (AD) or AD and related dementias (ADRD) are decades old and aimed at specialists. This evidence‐based guideline was developed to empower all—including primary care—clinicians to implement a structured approach for evaluating a ...
Alireza Atri, Bradford C. Dickerson, Carolyn Clevenger, Jason Karlawish, David Knopman, Pei‐Jung Lin, Mary Norman, Chiadi Onyike, Mary Sano, Susan Scanland, Maria Carrillo   +10 more
wiley   +1 more source

Glycolytic pathways: The hidden regulators in Parkinson's disease. [PDF]

Heliyon
Shen J, Yao E, Tian W, He J, Gu Y, Zhao D.   +5 more
europepmc   +1 more source

Cyclic Alternating Pattern Dynamics in Individuals at Risk for Developing Parkinson's Disease

Annals of Neurology, EarlyView.
Objective The objective of this study was to investigate the differences in cyclic alternating patterns (CAP) metrics, a non‐rapid eye movement (NREM) sleep physiological rhythm, among recently diagnosed patients with Parkinson's disease (PD), and individuals at high and low risk for developing PD based on genetic and prodromal risk.
Andrew Dagay, Shlomit Katzav, Danielle Wasserman, Valentina Gnoni, Anat Mirelman, Riva Tauman   +5 more
wiley   +1 more source

Rigidity in Parkinson's Disease: The Objective Effect of Levodopa. [PDF]

Mov Disord
Falletti M, Asci F, Zampogna A, Patera M, Pinola G, Centonze D, Hallett M, Rothwell J, Suppa A.   +8 more
europepmc   +1 more source

Blood DDIT4 and TRIM13 Transcript Levels Mark the Early Stages of Machado–Joseph Disease

Annals of Neurology, EarlyView.
Objective An abundance of select transcripts and proteins has been found to be dysregulated in blood samples of Machado–Joseph disease (MJD) carriers. Here, we aimed to: (1) identify blood transcriptional changes as potential biomarkers of MJD; (2) correlate levels of differentially expressed blood transcripts with MJD carriers features; and (3 ...
Ana F. Ferreira, Mafalda Raposo, Emily D. Shaw, Louisa Liu, João Vasconcelos, Teresa Kay, Conceição Bettencourt, Maria Luiza Saraiva‐Pereira, Laura Bannach Jardim, Maria do Carmo Costa, Manuela Lima   +10 more
wiley   +1 more source

The Regional Burden of Parkinson's Disease in Kazakhstan 2014-2021: Insights From National Health Data. [PDF]

Parkinsons Dis
Akhmedullin R, Gusmanov A, Zhakhina G, Crape B, Aimyshev T, Semenova Y, Kyrgyzbay G, Gaipov A.   +7 more
europepmc   +1 more source